- ICICI Lombard’s net income for the second quarter was 6.94 billion rupees, marking a 20% increase year-over-year.
- The net income surpassed estimates, which were projected at 6.8 billion rupees.
- A dividend of 5.50 rupees per share has been declared.
- The company reported gross written premiums of 69.5 billion rupees, reflecting an 11% increase compared to the previous year.
- The combined ratio stood at 104.5%, slightly higher than the previous year’s 103.9%.
- ICICI Lombard’s solvency ratio improved to 265% from the previous quarter’s 256%.
- Analyst recommendations include 18 buys, 6 holds, and 3 sells.
A look at ICICI Lombard General Insurance Company Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
ICICI Lombard General Insurance Company Limited, an insurance company operating in India, has shown a promising outlook according to the Smartkarma Smart Scores. With a strong dividend score of 4, the company is seen as a reliable option for investors seeking consistent returns. Additionally, boasting a growth score of 3, ICICI Lombard General Insurance demonstrates potential for long-term expansion in the insurance sector.
Furthermore, the company has received solid scores in resilience and momentum, both at 4, indicating its ability to weather economic uncertainties and maintain steady performance. While the value score stands at 2, potentially showing some room for improvement, ICICI Lombard General Insurance’s overall outlook remains positive, making it an enticing choice for investors looking for stability and growth in the insurance industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
